Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Your kid wants it now. What saying yes, no or not yet teaches kids about money and instant gratification. - 2Most loved Road Food: Which One Prevails upon You?
- 3Wegovy maker Novo sharpens consumer focus with board role for Mars CEO
- 4A 'rampaging lion' nebula roars to life in a stunning deep-space photo
- 5The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
- Israel says it killed armed Hamas 'terrorists' in Gaza
- Flu season is ramping up, and some experts are "pretty worried"
- 4 injured in shooting at North Carolina tree lighting ceremony
- Famous Versatile Brands: Your Decision
- Looking for under-the-radar adventures? Try Norway's Vesterålen
- The face is familiar, the name might not be. The king of "Hey, it's that guy!' roles is ready to show you his next act.
- Wedding Guest Outraged That Bride and Groom, Who Are in Their 60s and Have Both Been Married Before, Registered for Gifts
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
- Syrian army says recent drone attacks targeted its bases near Iraq, most shot down
